AstraZeneca says its new drug is the first to help reduce symptoms of chronic obstructive pulmonary disease, also known as COPD.
Two clinical trials showed that the monoclonal antibody known as tozorakimab reduced COPD symptoms by more than 30 percen… [690 chars]
Tuesday Health Report: New AstraZeneca drug may be first to reduce COPD symptoms, FDA approval sought
